Ubs Asset Management Americas Inc Myriad Genetics Inc Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 93,371 shares of MYGN stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,371

Previous 93,371 -0.0%

Holding current value

$2.33 Million

Previous $1.79 Million 11.36%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $111,354 - $161,704	6,964 Added 8.06%	93,371 $1.5 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $216,615 - $337,131	14,195 Added 19.66%	86,407 $2.01 Million
Q4 2022 Feb 14, 2023	SELL	$14.51 - $20.99 $36,942 - $53,440	-2,546 Reduced 3.41%	72,212 $1.05 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $38,641 - $59,161	-2,122 Reduced 2.76%	74,758 $1.43 Million
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $502,498 - $790,556	-30,547 Reduced 28.44%	76,880 $1.4 Million

Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $5,191 - $6,414	-229 Reduced 0.21%	107,427 $2.71 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $97,026 - $131,205	-4,021 Reduced 3.6%	107,656 $2.97 Million
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $353,256 - $432,111	11,787 Added 11.8%	111,677 $3.61 Million
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $484,491 - $622,264	19,082 Added 23.61%	99,890 $3.05 Million
Q1 2021 May 14, 2021	BUY	$19.92 - $31.6 $76,851 - $121,912	3,858 Added 5.01%	80,808 $2.46 Million
Q4 2020 Mar 01, 2021	SELL	$12.16 - $19.77 $35,069 - $57,016	-2,884 Reduced 3.61%	76,950 $1.52 Million
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $149,050 - $229,920	-13,943 Reduced 14.87%	79,834 $905,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $32,880 - $99,279	-3,362 Reduced 3.46%	93,777 $1.34 Million
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $33,969 - $56,967	1,623 Added 1.7%	97,139 $2.65 Million
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $243,409 - $519,009	11,024 Added 13.05%	95,516 $2.73 Million
Q2 2019 Aug 15, 2019	BUY	$22.67 - $35.0 $262,427 - $405,160	11,576 Added 15.88%	84,492 $0
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $425,844 - $548,711	15,813 Added 27.69%	72,916 $0
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $234,613 - $392,544	8,616 Added 17.77%	57,103 $1.66 Million
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $180,711 - $242,135	4,810 Added 11.01%	48,487 $0
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $228,965 - $331,442	-8,251 Reduced 15.89%	43,677 $0
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $28,080 - $39,943	974 Added 1.91%	51,928 $0
Q4 2017 Feb 09, 2018	BUY	$28.45 - $37.14 $74,396 - $97,121	2,615 Added 5.41%	50,954 $0
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $1.16 Million - $1.75 Million	48,339	48,339 $0

Others Institutions Holding MYGN

# of Institutions

191

Shares Held

94.2M

Call Options Held

280K

Put Options Held

14.3K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.01B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Myriad Genetics Inc Transaction History